跳至主要内容
临床试验/NCT05239767
NCT05239767已完成4 期

A Randomized Trial of NSAID Dosing Strategies

Montefiore Medical Center1 个研究点 分布在 1 个国家目标入组 407 人开始时间: 2022年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
407
试验地点
1
主要终点
Failure to achieve a minimum clinically important difference

研究概览

简要总结

This study will compare the efficacy of two different non-steroidal anti-inflammatory drugs (NSAIDs) ketorolac and ibuprofen for people with acute moderate or severe musculoskeletal pain. The investigators will also determine whether taking acetaminophen prior to the NSAID impacts efficacy

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

NSAID will be masked. Acetaminophen or no acetaminophen will not

入排标准

年龄范围
18 Years 至 69 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Acute musculoskeletal pain: Any pain attributable to muscles, bones, joints, tendons, ligaments or supporting structures, as determined by the clinical team, of 10 days duration or less. Prior to the onset of acute pain, patients cannot have experienced pain in the same body region during the prior six months
  • •Pain has to be described as moderate or severe, when the patient is asked if the pain is mild, moderate or severe in intensity

排除标准

  • •Contraindication to NSAIDs (allergy to NSAID or allergy to aspirin without history of tolerating NSAIDs, history of gastrointestinal bleeding, daily medication for gastritis or PUD, chronic kidney disease 2-5, heart failure)
  • •Contraindication to acetaminophen (hepatitis or cirrhosis)
  • •Use of an NSAID within the previous eight hours
  • •Use of acetaminophen within the previous eight hours
  • •Chronic pain, defined as any pain on >50% of days for at least 3 months prior to onset of acute pain
  • •Recurrent pain in the same body part as the presenting complaint

研究组 & 干预措施

Ibuprofen

Active Comparator

Ibuprofen 800mg orally x 1

干预措施: NSAID (Drug)

Ketorolac

Active Comparator

Ketorolac 20mg orally x 1

干预措施: NSAID (Drug)

结局指标

主要结局

Failure to achieve a minimum clinically important difference

时间窗: Two hours

Failure to improve by at least 1.3 points on a 0-10 pain scale

次要结局

  • Epigastric pain(Two hours after medication administration)
  • 0-10 pain score(One and two hours after medication administration)
  • Ordinal pain scale(One and two hours after medication administration)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验